Daily Archives: 12th February 2019

The Medicines EFFECTS Committee is advising patients who are employing Celebrex.

The Medicines EFFECTS Committee is advising patients who are employing Celebrex, Arcoxia, Mobic and Bextra they should talk with their health care provider about alternatives if they have concerns. The Medicines Adverse Reactions Committee has talked about an instant literature review of the chance useful of COX 2 inhibitor medicine causing increased risk of cardiovascular events . The MARC figured the increased risk of heart attack found for rofecoxib may also occur to some extent for all the other associates of the COX 2 band of anti-inflammatory brokers. The MARC bottom line is supported by the next report from america National Institute of Health that it had stopped one of two long-term studies of celecoxib in preventing colon polyps due to an increased risk of cardiovascular occasions. Continue reading